Acadia Pharmaceuticals Inc (ACAD): Shareholders' Equity
$1.23B
As of 2025-12-31
$1.31B
As of 2026-06-30
+45.3%
3-year compound annual growth
+14.4%
5-year compound annual growth
+19.9%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.23B | +67.5% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $732.79M | +69.7% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $431.75M | +7.8% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $400.41M | -26.0% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $540.89M | -13.7% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $627.01M | -10.3% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $699.13M | +45.9% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $479.08M | +42.9% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $335.29M | -35.3% | 2020-02-27, Balance as of period end |
| 2016-12-31 | $518.41M | +159.5% | 2019-02-27, Balance as of period end |
| 2015-12-31 | $199.76M | -35.5% | 2018-02-27, Balance as of period end |
| 2014-12-31 | $309.49M | +69.9% | 2017-02-28, Balance as of period end |
| 2013-12-31 | $182.13M | +114.3% | 2016-02-29, Balance as of period end |
| 2012-12-31 | $84.98M | +263.8% | 2015-02-26, Balance as of period end |
| 2011-12-31 | $23.36M | -21.3% | 2014-02-27, Balance as of period end |
| 2010-12-31 | $29.69M | +145.1% | 2013-03-12, Balance as of period end |
| 2009-12-31 | $12.11M | n/a | 2012-03-06, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.23B | +67.5% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.89B | +2.9% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $602.69M | -20.1% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $489.09M | -16.9% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | -$98.00M | n/m |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $540.72M | +33.9% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $870.22M | +32.0% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $503.42M | +163.5% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $301.68M | +31.8% |
Compare ACAD, PBH, MDGL, IONS side by side · Screen every company in Pharmaceutical Preparations ↗